SNY
Sanofi ADR
NASDAQ: SNY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$46.58
+1.19% today
Updated 2026-04-30
Market cap
$110.28B
P/E ratio
19.84
P/S ratio
2.33x
EPS (TTM)
$2.32
Dividend yield
—
52W range
$43 – $53
Volume
3.5M
Sanofi ADR (SNY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.49B | $29.21B | $28.82B | $30.75B | $34.04B | $35.06B | $35.96B | $31.29B | $32.00B | $34.86B | $34.70B | $36.22B | $35.68B | $37.63B | $37.37B | $39.17B | $40.56B | $41.62B | $44.29B | $46.72B |
| Revenue growth (YoY) | — | -1.0% | -1.3% | +6.7% | +10.7% | +3.0% | +2.6% | -13.0% | +2.3% | +8.9% | -0.5% | +4.4% | -1.5% | +5.5% | -0.7% | +4.8% | +3.5% | +2.6% | +6.4% | +5.5% |
| Cost of revenue | $7.59B | $7.57B | $7.34B | $7.88B | $9.40B | $10.87B | $11.10B | $10.30B | $10.23B | $10.92B | $10.70B | $11.61B | $11.44B | $11.98B | $12.16B | $12.26B | $11.88B | $12.63B | $13.21B | $12.92B |
| Gross profit | $21.90B | $21.64B | $21.48B | $22.87B | $24.64B | $24.19B | $24.86B | $20.99B | $21.77B | $23.94B | $24.00B | $24.61B | $24.24B | $25.65B | $25.21B | $26.92B | $28.68B | $28.99B | $31.08B | $33.79B |
| Gross margin | 74.3% | 74.1% | 74.5% | 74.4% | 72.4% | 69.0% | 69.1% | 67.1% | 68.0% | 68.7% | 69.2% | 67.9% | 67.9% | 68.2% | 67.5% | 68.7% | 70.7% | 69.7% | 70.2% | 72.3% |
| R&D | $4.43B | $4.54B | $4.58B | $4.58B | $4.55B | $4.79B | $4.91B | $4.61B | $4.67B | $5.08B | $5.17B | $5.47B | $5.89B | $6.02B | $5.53B | $5.69B | $6.50B | $6.51B | $7.39B | $7.84B |
| SG&A | $8.02B | $7.87B | $16.35B | $17.07B | $582.00M | $28.00M | $182.00M | $495.00M | $542.00M | $114.00M | $106.00M | $106.00M | $75.00M | $1.00M | $1.00M | $9.55B | $10.49B | $10.69B | $9.18B | $10.24B |
| Operating income | $5.73B | $5.91B | $4.39B | $6.37B | $6.54B | $5.86B | $6.43B | $4.98B | $6.06B | $5.62B | $6.53B | $5.80B | $4.68B | $3.05B | $14.11B | $8.13B | $10.16B | $6.96B | $7.25B | $6.34B |
| Operating margin | 19.4% | 20.2% | 15.2% | 20.7% | 19.2% | 16.7% | 17.9% | 15.9% | 19.0% | 16.1% | 18.8% | 16.0% | 13.1% | 8.1% | 37.8% | 20.7% | 25.1% | 16.7% | 16.4% | 13.6% |
| EBITDA | $12.12B | $10.77B | $10.48B | $11.40B | $11.77B | $11.55B | $11.43B | $10.19B | $9.54B | $10.08B | $9.90B | $9.64B | $9.18B | $10.66B | $17.88B | $11.54B | $13.51B | $11.39B | $11.03B | $12.68B |
| EBITDA margin | 41.1% | 36.9% | 36.4% | 37.1% | 34.6% | 33.0% | 31.8% | 32.6% | 29.8% | 28.9% | 28.5% | 26.6% | 25.7% | 28.3% | 47.9% | 29.5% | 33.3% | 27.4% | 24.9% | 27.1% |
| EBIT | $6.00B | $6.10B | $4.50B | $6.39B | $6.64B | $6.00B | $6.52B | $5.09B | $6.26B | $5.80B | $6.60B | $5.95B | $4.90B | $3.22B | $14.21B | $8.19B | $10.40B | $6.96B | $7.45B | $9.47B |
| Interest expense | $358.52M | $278.47M | $318.82M | $300.51M | $391.01M | $503.29M | $483.40M | $457.00M | $451.83M | $423.38M | $399.50M | $333.43M | $486.48M | $536.27M | $430.84M | $377.37M | $384.80M | $512.82M | $622.58M | $540.78M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $4.01B | $5.26B | $3.85B | $5.26B | $5.47B | $5.65B | $4.89B | $3.72B | $4.39B | $4.29B | $4.71B | $8.42B | $4.31B | $2.75B | $12.29B | $6.22B | $8.37B | $5.40B | $5.56B | $7.81B |
| Net income growth (YoY) | — | +31.4% | -26.8% | +36.7% | +3.8% | +3.3% | -13.4% | -24.0% | +18.1% | -2.3% | +9.8% | +78.7% | -48.8% | -36.0% | +346.4% | -49.4% | +34.5% | -35.5% | +3.0% | +40.5% |
| Profit margin | 13.6% | 18.0% | 13.4% | 17.1% | 16.1% | 16.1% | 13.6% | 11.9% | 13.7% | 12.3% | 13.6% | 23.2% | 12.1% | 7.3% | 32.9% | 15.9% | 20.6% | 13.0% | 12.6% | 16.7% |